ZVH-40247-20563 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-25
Dose 1 — Moderna
2021-02-26
Dose 2 — Moderna
2021-03-01
Registered in v-safe
2021-03-01
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Rash, not including the immediate area around the injection site

Adult check-in
2021-03-02
Survey response — days 1–6 daily, dose 2
MedDRA: Rash, Self-medication, Specialist consultation — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Systemic reaction (other): Rash started last night which was 3 days after 2nd dose. Developed first on non injection arm and then spread to both arms, chest, back and upper legs. Resolved 99% by morning following several Benedryl 25 mg doses. Nothing other than the vaccine different to explain the rash. No fever and vitals stable throughout the episode. · Healthcare visit (other): I consulted my rheumatologist as I was told to hold my methotrexate for 1 week post vaccine. He said safe to miss the dose despite the rash.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-02
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-05
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-08-27
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-21
Call 1 — Left Voicemail
2021-09-21
Call successful
Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-25	Moderna
2	2021-02-26	Moderna

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 2

2021-03-02

Systemic reaction (other): Rash started last night which was 3 days after 2nd dose. Developed first on non injection arm and then spread to both arms, chest, back and upper legs. Resolved 99% by morning following several Benedryl 25 mg doses. Nothing other than the vaccine different to explain the rash. No fever and vitals stable throughout the episode.

Healthcare visit (other): I consulted my rheumatologist as I was told to hold my methotrexate for 1 week post vaccine. He said safe to miss the dose despite the rash.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Rash	✓	✓	✓
HCVO	Specialist consultation	✓	✓	✓
SRO	Rash	✓	✓	✓
SRO	Self-medication	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release